Imaging Tumor-infiltrating T-cells in Non-small Cell Lung Cancer
NCT03853187
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Non-small Cell Lung Cancer
Interventions
RADIATION:
Zr-89 labelled durvalumab PET/CT
DRUG:
Durvalumab (MEDI4736)
Sponsor
Radboud University Medical Center
Collaborators
[object Object]